Amai Proteins Expands Asia Reach With sweelin®
Rehovot, Israel, May 25, 2026 Amai Proteins has announced a major regulatory breakthrough after receiving approval from the Singapore...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Rehovot, Israel, May 25, 2026 Amai Proteins has announced a major regulatory breakthrough after receiving approval from the Singapore...
Hudson, Wis. – October 27, 2025: CIRANDA announced a strategic partnership with Incredo to deliver transformational, clean-label sugar solutions...
